EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cost-utility analysis of real-time artificial intelligence-assisted colonoscopy in Italy

Cesare Hassan, Massimiliano Povero iD, Lorenzo Pradelli, Marco Spadaccini iD, Alessandro Repici

Endoscopy International Open · 2023-11 · 11 (11) · E1046-E1055

DOI: 10.1055/a-2136-3428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, online erschienen am 10.11.2023. Verfasst von Cesare Hassan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Endoscopy Unit, Humanitas University, Rozzano, Italy. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and study aims Artificial intelligence (AI)-assisted colonoscopy has proven to be effective compared with colonoscopy alone in an average-risk population. We aimed to evaluate the cost-utility of GI GENIUS, the first marketed real-time AI system in an Italian high-risk population.

Methods

A 1-year cycle cohort Markov model was developed to simulate the disease evolution of a cohort of Italian individuals positive on fecal immunochemical test (FIT), aged 50 years, undergoing colonoscopy with or without the AI system. Adenoma or colorectal cancer (CRC) were identified according to detection rates specific for each technique. Costs were estimated from the Italian National Health Service perspective.

Results

Colonoscopy+AI system was dominant with respect to standard colonoscopy. The GI GENIUS system prevented 155 CRC cases (–2.7%), 77 CRC-related deaths (–2.8%), and improved quality of life (+0.027 QALY) with respect to colonoscopy alone. The increase in screening cost (+€10.50) and care for adenoma (+€3.53) was offset by the savings in cost of care for CRC (–€28.37), leading to a total savings of €14.34 per patient. Probabilistic sensitivity analysis confirmed the cost-efficacy of the AI system (almost 80% probability).

Conclusions

The implementation of AI detection tools in colonoscopy after patients test FIT-positive seems to be a cost-saving strategy for preventing CRC incidence and mortality.

Schlagwörter

Stichwörter der Autor:innen

CRC screeningColorectal cancerEndoscopy Lower GI TractStatistics

Autor:innen und Institutionen

  • Endoscopy Unit, Humanitas University, Rozzano, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
  • HE&OR, AdRes, Turin, Italy.

ORCID-Profile: Massimiliano Povero, Marco Spadaccini

Zitieren

APA

Hassan, C., Povero, M., Pradelli, L., Spadaccini, M., & Repici, A. (2023). Cost-utility analysis of real-time artificial intelligence-assisted colonoscopy in Italy. Endoscopy International Open, 11(11), E1046-E1055. https://doi.org/10.1055/a-2136-3428

Vancouver

Hassan C, Povero M, Pradelli L, Spadaccini M, Repici A. Cost-utility analysis of real-time artificial intelligence-assisted colonoscopy in Italy. Endoscopy International Open. 2023;11(11):E1046-E1055. doi:10.1055/a-2136-3428

BibTeX
@article{Hassan2023,
  author = {Hassan, Cesare and Povero, Massimiliano and Pradelli, Lorenzo and Spadaccini, Marco and Repici, Alessandro},
  title = {Cost-utility analysis of real-time artificial intelligence-assisted colonoscopy in Italy},
  journal = {Endoscopy International Open},
  year = {2023},
  volume = {11},
  number = {11},
  pages = {E1046--E1055},
  doi = {10.1055/a-2136-3428}
}
Kostenlos starten →